A detailed history of Laffer Tengler Investments transactions in Abbott Laboratories stock. As of the latest transaction made, Laffer Tengler Investments holds 3,288 shares of ABT stock, worth $375,588. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,288
Previous 3,288 -0.0%
Holding current value
$375,588
Previous $342 Million 9.72%
% of portfolio
0.08%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $125,838 - $138,983
1,149 Added 53.72%
3,288 $374 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $5,321 - $6,513
59 Added 2.84%
2,139 $235 Million
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $114,832 - $134,716
-1,208 Reduced 36.74%
2,080 $228 Million
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $383,578 - $424,349
3,288 New
3,288 $388 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $331,651 - $390,401
-3,135 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $114,826 - $135,282
1,055 Added 50.72%
3,135 $376 Million
Q4 2020

Jun 11, 2021

BUY
$105.0 - $114.42 $218,400 - $237,993
2,080 New
2,080 $226 Million
Q4 2020

Feb 19, 2021

SELL
$105.0 - $114.42 $218,400 - $237,993
-2,080 Closed
0 $0
Q3 2020

Jun 11, 2021

SELL
$91.64 - $111.29 $27,766 - $33,720
-303 Reduced 12.72%
2,080 $226 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $27,766 - $33,720
303 Added 14.57%
2,383 $259 Million
Q2 2020

Jun 11, 2021

BUY
$76.57 - $98.0 $159,265 - $203,840
2,080 New
2,080 $190 Million
Q1 2020

Apr 28, 2020

SELL
$62.82 - $91.86 $225,084 - $329,134
-3,583 Closed
0 $0
Q4 2019

Feb 20, 2020

BUY
$78.51 - $87.4 $279,103 - $310,707
3,555 Added 12696.43%
3,583 $311 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $2,291 - $2,484
28 New
28 $2.34 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Laffer Tengler Investments Portfolio

Follow Laffer Tengler Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

News

Stay updated on Laffer Tengler Investments with notifications on news.